Send Inquiry

Request To Call Back

Nimotuzumab Injection

Get a Price/Quote

MOQ : 10 Boxes

Nimotuzumab Injection Specification

Application
Hospital, Clinical, Cancer Therapy

Grade
Pharmaceutical Grade

Purity
>99% Pure

CAS No
406730-17-0

Molecular Formula
C6452H9954N1714O2020S42

Formulations Type
Injectables

Formulations Form
Liquid

Treatments & Functions
Used for Cancer Immunotherapy, Treats Head and Neck Cancer, Glioma

Gender/Age Group
Adult

Dosage Guidelines
As Directed by Physician

Volume
10 ml

Storage Instructions
Store in Cool

Packaging Size
1 Vial

Side Effects
Mild Fever, Skin Rash, Fatigue (Consult Physician)

Manufactured By
Leading Pharmaceutical Company

Route of Administration
Intravenous Injection

Shelf Life
24 Months

Prescription/Non Prescription
Prescription

Usage
Monoclonal Antibody for Tumor Therapy

Strength
50mg per 10ml

Brand Name
Nimotuzumab

Suitable For
Adults

Nimotuzumab Injection Trade Information

Minimum Order Quantity
10 Boxes

FOB Port
Mundra Port

Payment Terms
Letter of Credit (L/C), Telegraphic Transfer (T/T), Paypal, Western Union, Letter of Credit at Sight (Sight L/C), Cash in Advance (CID), Cash Advance (CA)

Supply Ability
10000 Boxes box Per Month

Delivery Time
30 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
As Per Buyer Requirements

Main Domestic Market
All India

Certifications
ISO, GMP, WHO, FDA

About Nimotuzumab Injection

Nimotuzumab Injection

Product Description
We are considered as one of the leading exporters of an excellent quality Nimotuzumab Injection. Nimotuzumab Injection is procured from the reputed vendors in the market after inspecting its quality on various standard quality parameters like composition and effectiveness. The Nimotuzumab Injection is formulated in complete compliance with medical standards using best quality compounds. Our clients can get this Nimotuzumab Injection from us at highly competitive price.

Key points:
The drug is a humanized monoclonal antibody
It binds to a signaling protein known as epidermal growth factor receptor (EGFR) that normally controls cell division.

Specifications:

Brand: Biomab
Contain: Nimotuzumab Injection
Type: Injection
Packing: vail

Features:

Reasonable price
Fast transportation
Easy accessible

Advanced Therapy for Cancer Immunotherapy

Nimotuzumab Injection is designed as a targeted monoclonal antibody for cancer immunotherapy. It specifically acts against tumors, enhancing the bodys immune response to malignant cells. Used in treating head and neck cancers as well as glioma, Nimotuzumab offers a promising solution for adult patients and is administered under the supervision of medical professionals in hospital settings.

Precision Formulation with High Purity

Nimotuzumabs formulation maintains a purity exceeding 99%, adhering to strict pharmaceutical grade standards. Packaged as a single vial containing 50mg in 10ml, it is presented as an injectable liquid for intravenous use. The product must be stored in cool conditions and is noted for having a shelf life of 24 months, ensuring stability and efficacy throughout its usage period.

FAQs of Nimotuzumab Injection:

Q: How is Nimotuzumab Injection administered for cancer therapy?

A: Nimotuzumab Injection is given intravenously by qualified healthcare providers, typically in hospital or clinical settings. Each dose is carefully prepared and administered directly into the bloodstream, with dosage guided strictly by a physician.

Q: What types of cancers are treated with Nimotuzumab Injection?

A: Nimotuzumab is primarily used to treat head and neck cancers as well as brain tumors like glioma. Its monoclonal antibody properties target specific tumor cells, supporting effective cancer immunotherapy.

Q: When should Nimotuzumab Injection be used during cancer treatment?

A: This medication is usually incorporated into a cancer therapy regimen as directed by an oncologist. The timing and frequency depend on individual patient needs, cancer stage, and response to prior treatments.

Q: Where should Nimotuzumab Injection be stored before administration?

A: Nimotuzumab Injection should be stored in a cool environment, following the manufacturers recommendations to preserve its potency. Hospitals and clinics ensure optimal storage conditions until use.

Q: What is the process for receiving Nimotuzumab Injection?

A: Patients undergo an evaluation by their oncologist, and if deemed suitable, receive Nimotuzumab intravenously in a controlled clinical setting. Medical staff monitor the infusion and patient for potential side effects.

Q: What benefits does Nimotuzumab Injection offer in cancer therapy?

A: Nimotuzumab provides targeted immune system support against tumor cells, which can enhance treatment outcomes in head and neck cancers and glioma. Its specificity helps reduce harm to healthy tissues.

Q: Are there any side effects associated with Nimotuzumab Injection?

A: Common side effects include mild fever, skin rash, and fatigue. If these symptoms arise, patients should consult their physician promptly for assessment and management.

Tell us about your requirement